National Health Investors (NHI)
NYSE:NHI

National Health Investors (NHI) Stock Forecast & Price Target

565 Followers
See the Price Targets and Ratings of:

NHI Analyst Ratings

Hold
1Ratings
0 Buy
1 Hold
0 Sell
Based on 1 analysts giving stock ratings to
National
Health Investors
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NHI Stock 12 Months Forecast

Average Price Target

$61.00
▲(8.14% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $61.00 with a high forecast of $61.00 and a low forecast of $61.00. The average price target represents a 8.14% change from the last price of $56.41.
Highest Price Target$61.00Average Price Target$61.00Lowest Price Target$61.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Berenberg Bank
$66.00
Hold
17.00%
Upside
Reiterated
Berenberg Bank Reaffirms Their Hold Rating on National Health Investors (NHI)
Stifel Nicolaus
$66.00
Hold
17.00%
Upside
Reiterated
National Health Investors (NHI) PT Raised to $66 at StifelStifel analyst Stephen Manaker raised the price target on National Health Investors (NYSE: NHI) to $66.00 (from $56.00) while maintaining a Hold rating.
BMO Capital
$64.00
Hold
13.46%
Upside
Reiterated
BMO Capital Remains a Hold on National Health Investors (NHI)
Credit Suisse
$51.00
Sell
-9.59%
Downside
Initiated
National Health Investors initiated with an Underperform at Credit SuisseNational Health Investors initiated with an Underperform at Credit Suisse
Capital One Financial
$64.00
Buy
13.46%
Upside
Initiated
National Health Investors reinstated with an Overweight at Capital OneNational Health Investors reinstated with an Overweight at Capital One
Stocks with the Highest Top Analyst Consensus in the Financial Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

NHI Financial Forecast

NHI Earnings Forecast
Next quarter’s earnings estimate for NHI is $0.83 with a range of $0.83 to $0.83. The previous quarter’s EPS was $0.78. NHI beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 62.62% of the time in the same period. In the last calendar year NHI has Underperformed its overall industry.
Next quarter’s earnings estimate for NHI is $0.83 with a range of $0.83 to $0.83. The previous quarter’s EPS was $0.78. NHI beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 62.62% of the time in the same period. In the last calendar year NHI has Underperformed its overall industry.
NHI Sales Forecast
Next quarter’s sales forecast for NHI is $63.74M with a range of $50.80M to $74.11M. The previous quarter’s sales results were $76.36M. NHI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 77.96% of the time in the same period. In the last calendar year NHI has Outperformed its overall industry.
Next quarter’s sales forecast for NHI is $63.74M with a range of $50.80M to $74.11M. The previous quarter’s sales results were $76.36M. NHI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 77.96% of the time in the same period. In the last calendar year NHI has Outperformed its overall industry.
NHI Analyst Recommendation Trends
In the current month, NHI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NHI average analyst price target in the past 3 months is $61.00
In the current month, NHI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NHI average analyst price target in the past 3 months is $61.00

NHI Stock Forecast FAQ

What is NHI’s average 12-month price target, according to analysts?
Based on analyst ratings, National Health Investors’s 12-month average price target is $61.00.
    What is NHI’s upside potential, based on the analysts’ average price target?
    National Health Investors has 8.14% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is NHI a Buy, Sell or Hold?
          National Health Investors has a conensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
            What is National Health Investors’s price target?
            The average price target for National Health Investors is $61.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $61.00 ,the lowest forecast is $61.00. The average price target represents 8.14% Increase from the current price of $56.41.
              What do analysts say about National Health Investors?
              National Health Investors’s analyst rating consensus is a ‘Hold. This is based on the ratings of 1 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis